Concepedia

Author

Elisabetta Terruzzi

Azienda Ospedaliera San Gerardo

Also Known As

E Terruzzi, E. Terruzzi, Elisabetta Terruzzi

66

Publications

2.2K

Citations

17

H-Index

27

Concepts

All Affiliations

Azienda Ospedaliera San GerardoIstituti di Ricovero e Cura a Carattere ScientificoAzienda Sanitaria Ospedaliera S.Croce e Carle CuneoAzienda Ospedaliero-Universitaria CareggiUniversity of Milan
ET

About

Elisabetta Terruzzi is an author at Azienda Ospedaliera San Gerardo specializing in medicine, hematology, and marrow transplantation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

8

8

419

2

Blood Transplantation

4

4

279

3

Cellular Therapies

2

2

44

4

Health Sciences

1

1

14

5

Epidemiology

1

1

22

Elisabetta Terruzzi

×

21

Publications

2K

Citations

16

H-Index

YearCitations

Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease

Nicolaus Kröger, Carlos Solano, Christine Wolschke,

New England Journal of Medicine

2016

541

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL)

Renato Bassan, Orietta Spinelli, Elena Oldani,

Blood

2009

429

Chemotherapy-Phased Imatinib Pulses Improve Long-Term Outcome of Adult Patients With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia: Northern Italy Leukemia Group Protocol 09/00

Renato Bassan, Giuseppe Rossi, Enrico Maria Pogliani,

Journal of Clinical Oncology

2010

271

Busulfan plus cyclophosphamide versus busulfan plus fludarabine as a preparative regimen for allogeneic haemopoietic stem-cell transplantation in patients with acute myeloid leukaemia: an open-label, multicentre, randomised, phase 3 trial

Alessandro Rambaldi, Anna Grassi, Arianna Masciulli,

The Lancet Oncology

2015

176

Management of poor peripheral blood stem cell mobilization: Incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions

Paolo Perseghin, Elisabetta Terruzzi, Maria Dassi,

Transfusion and Apheresis Science

2009

87

Achieving Molecular Remission before Allogeneic Stem Cell Transplantation in Adult Patients with Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia: Impact on Relapse and Long-Term Outcome

Federico Lussana, Tamara Intermesoli, Francesca Gianni,

Biology of Blood and Marrow Transplantation

2016

86

GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised study

Francesca Bonifazi, Carlos Solano, Christine Wolschke,

The Lancet Haematology

2019

56

High cure rates in Burkitt lymphoma and leukemia: a Northern Italy Leukemia Group study of the German short intensive rituximab-chemotherapy program

Tamara Intermesoli, Alessandro Rambaldi, Giuseppe Rossi,

Haematologica

2013

48

Cytomegalovirus infection after autologous stem cell transplantation: incidence and outcome in a group of patients undergoing a surveillance program

Fausto Rossini, Elisabetta Terruzzi, Simona Cammarota,

Transplant Infectious Disease

2005

41

Allogeneic Hemopoietic Stem Cell Transplants in Patients with Acute Myeloid Leukemia (AML) Prepared with Busulfan and Fludarabine (BUFLU) or Thiotepa, Busulfan, and Fludarabine (TBF): A Retrospective Study

Federica Sorà, Carmen Di Grazia, Patrizia Chiusolo,

Biology of Blood and Marrow Transplantation

2019

37

Page 1